SELVAS Healthcare, Inc. (KOSDAQ:208370)

Market Cap	126.79B +10.0%
Revenue (ttm)	29.79B +1.8%
Net Income	2.34B +9.6%
EPS	90.55 +9.2%
Shares Out	25.72M
PE Ratio	54.45
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	279,547
Average Volume	610,983
Open	5,010.00
Previous Close	5,010.00
Day's Range	4,910.00 - 5,050.00
52-Week Range	3,405.00 - 7,490.00
Beta	-1.03
RSI	39.33
Earnings Date	Mar 19, 2026

About SELVAS Healthcare

SELVAS Healthcare, Inc. operates as a medical device company in South Korea. The company provides body composition analyzers and automatic blood pressure monitors for hospitals. It also offers Braille Sense notetakers and other products for blind and visually impaired people under the HIMS brand name, as well as provides digital health products under the ACCUNIQ brand name. In addition, The company provides daisy players, handheld, and desktop magnifiers. Its products are used in hospitals, medical facilities, doctor's offices, weight loss cent...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1993
• Employees: 128
• Stock Exchange: KOSDAQ
• Ticker Symbol: 208370

Financial Performance

In 2024, SELVAS Healthcare's revenue was 31.70 billion, an increase of 6.34% compared to the previous year's 29.81 billion. Earnings were 3.15 billion, a decrease of -39.03%.